Subtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis)

PeerJ

Volumn 2014, Issue 1, 2014, Pages

  Kantanen, Mari ^a   Kiuru Enari, Sari ^a,b   Salonen, Oili ^a   Kaipainen, Markku ^a   Hokkanen, Laura ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Depression; Gelsolin amyloidosis; Hereditary amyloidosis; Magnetic resonance imaging; Neuropsychological testing; Visuoconstructional problems

Indexed keywords

EID: 84905698494     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.493     Document Type: Article

References (54)

1. Arvanitakis Z, Leurgans SE,Wang Z,Wilson RS, Bennett DA, Schneider JA. 2011. Cerebral amyloid angiopathy and cognitive domains in older persons. Annals of Neurology 69:320-327 DOI 10.1002/ana.22112.
2. Beck AT, Steer RA, Brown GK. 1987. Manual for the Beck depression inventory. San Antonio, TX: The Psychological Corporation.
3. Beck AT, Steer RA, Brown GK. 2004. Beck depression inventory II, Beckin depressioasteikko II, K̈asikirja. Suomalainen laitos. Helsinki: Psykologien Kustannus Oy.
4. BiffiA, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H, Jimenez-Conde J, Hansen BM, Fernandez-Cadenas I, Cortellini L, Ayres A, Schwab K, Juchniewicz K, Urbanik A, Rost NS, Viswanathan A, Seifert-Held T, Stoegerer EM, Tomáas M, Rabionet R, Estivill X, Brown DL, Silliman SL, Selim M,Worrall BB,Meschia JF,Montaner J, Lindgren A, Roquer J, Schmidt R, Greenberg SM, Slowik A, Broderick JP,Woo D, Rosand J, International Stroke Genetics Consortium. 2010. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Annals of Neurology 68:934-943 DOI 10.1002/ana.22134
5. Bonelli RM, Cummings JL. 2007. Frontal-subcortical circuitry and behavior. Dialogues in Clinical Neuroscience 9(2):141-151.
6. Caplan BM, Romans S. 1998. Assessment of spatial abilities. In: Goldstein G, Nussbaum PD, Beers SR, eds. Neuropsychology. New York: Plenum Press.
7. Chao CP, Kotsenas AL, Broderick DF. 2006. Cerebral amyloid angiopathy: CT and MR imaging findings. RadioGraphics 26:1517-1531 DOI 10.1148/rg.265055090.
8. Charidimou A, Gang Q,Werring DJ. 2012. Sporadic cerebral amyloid angiopathy revisited: recent insight into pathophysiology and clinical spectrum. Journal of Neurology, Neurosurgery and Psychiatry 83:124-137 DOI 10.1136/jnnp-2011-301308.
9. Christensen AL. 1974. Luria's neuropsychological investigation. Copenhagen: Munksgaard.
10. Corrigan JD, Hinkeldey NS. 1987. Relationships between parts A and B of the trail making test. Journal of Clinical Psychology 43:402-408 DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E.
11. Cummings JL. 1990. Frontal-subcortical circuits and human behaviour. Archives of Neurology 50(8):873-880 DOI 10.1001/archneur.1993.00540080076020.
12. Darras BT, Adelman LS,Mora JS, Bodziner RA,Munsat TL. 1986. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. Neurology 36:432-435 DOI 10.1212/WNL.36.3.432.
13. Derogatis LR, Lipman RS, Covi L. 1973. SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacology 9:13-28.
14. Farlow M, Ghetti B, Benson MD, Farlow JS, van Nostrand WE,Wagner SL. 1992. Low cerebrospinal-fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease. Lancet 340:453-454 DOI 10.1016/0140-6736(92)91771-Y.
15. Fazekas F, Chawluk JB, Alavi A, Hurtig H, Zimmerman RA. 1987. MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging. American Journal of Neuroradiology 8:421-426.
16. First MB, Gibbon M, Spitzer RL,Williams JBW, Benjamin LS. 1997. Structured clinical interview for DSM-IV axis II personality disorders, (SCID-II). Washington, D.C.: American Psychiatric Press, Inc.
17. First MB, Spitzer RL, Gibbon M,Williams JBW. 1996. Structured clinical interview for DSM-IV axis I disorders. In: Clinician version (SCID-CV). Washington, D.C.: American Psychiatric Press, Inc.
18. Greenberg SM, Gurol ME, Rosand J, Smith EE. 2004. Amyloid angiopathy-related vascular cognitive impairment. Stroke 35:2616-2619 DOI 10.1161/01.STR.0000143224.36527.44.
19. Gregoire SM, Smith K, J̈ager HR, Benjamin M, Kallis C, Brown MM, Cipolotti L,Werring DJ. 2012. Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients. Cerebrovascular Diseases 33(5):430-435 DOI 10.1159/000336237.
20. Gronwall DMA. 1977. Paced auditory serial-addition task: a measure of recovery from concussion. Perceptual and Motor Skills 44:367-373 DOI 10.2466/pms.1977.44.2.367.
21. Haan J, Roos RAC, Algra PR, Lanser JB, Bots GT, Vegter-van der Vlis M. 1990. Hereditary cerebral haemorrhage with amyloidosis-Dutch type. Magnetic resonance imaging findings in 7 cases. Brain 113(5):1251-1267 DOI 10.1093/brain/113.5.1251.
22. Haltia M, Ghiso J,Wisniewski T, Kiuru S,Miller D, Frangione B. 1991. Gelsolin variant and β-amyloid co-occur in a case of Alzheimer's with Lewy bodies. Neurobiology of Aging 12:313-316 DOI 10.1016/0197-4580(91)90007-7
23. Holi MM,Marttunen M, Aalberg V. 2003. Comparison of the GHQ-36, the GHQ-12 and the SCL-90 as psychiatric screening instruments in the Finnish population. Nordic Journal of Psychiatry 57(3):233-238 DOI 10.1080/08039480310001418.
24. Holi MM, Sammallahti PR, Aalberg VA. 1998. A Finnish validation study of the SCL-90. ACTA Psychiatrica Scandinavica 97(1):42-46 DOI 10.1111/j.1600-0447.1998.tb09961.x.
25. Hommet C,Mondon K, Constans T, Beaufils E, Desmidt T, Camus V, Cottier JP. 2011. Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds. Dementia and Geriatric Cognitive Disorders 32:367-378 DOI 10.1159/000335568.
26. IBM Corp. 2012. SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.
27. Jensen AR, Rohwer WD. 1966. The stroop color-word test: a review. Acta Psychologica 25:36-93 DOI 10.1016/0001-6918(66)90004-7.
28. Keage H, Carare R, Friedland R, Ince PG, Love S, Nicoll JA,Wharton SB,Weller RO, Brayne C. 2009. Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurology 9:3 DOI 10.1186/1471-2377-9-3.
29. Kiuru-Enari S, Haltia M. 2013. Hereditary gelsolin amyloidosis. In: Said G, Krarup C, eds. Peripheral nerve disorders, Handbook of clinical neurology. Amsterdam: Elsevier.
30. Kiuru S, Salonen O, Haltia M. 1999. Gelsolin-related spinal and cerebral amyloidangiopathy. Annals of Neurology 45:305-311DOI 10.1002/1531-8249(199903)45:3<305::AID-ANA5>3.0.CO;2-E.
31. Kiuru S, Sepp̈al̈ainen A-M, Salonen O, Hokkanen L, Somer H, Palo J. 1995. CNS abnormalities in patients with familial amyloidosis of the Finnish type (FAF). Amyloid: The Journal of Protein Folding Disorders 2:22-30 DOI 10.3109/13506129509031884.
32. Koennecke HC. 2006. Cerebral microbleeds on MRI. Prevalence, associations, and potential clinical implications. Review. Neurology 66:165-171 DOI 10.1212/01.wnl.0000194266.55694.1e
33. Lezak MD, Howieson DB, Loring DW. 2004. Neuropsychological assessment, 4th edition. New York: Oxford University Press.
34. Meretoja J. 1969. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Annals of Clinical Research 1:314-324.
35. Naarding P, Schoevers RA, Janzing JG, Jonker C, Koudstaal PJ, Beekman AT. 2005. A study on symptom profiles of late-life depression: the influence vascular, degenerative and inflammatory risk-indicators. Journal of Affective Disorders 88:155-162 DOI 10.1016/j.jad.2005.07.002.
36. Paunio T, Kiuru S, Hongell V,Mustonen E, Syv̈anen AC, Bengstr̈om M, Palo J, Peltonen L. 1992. Solid-phase minisequencing reveals Asp187-Asn (G654-A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 13:237-239 DOI 10.1016/0888-7543(92)90235-K.
37. Pfeifer LA,White LR, Ross GW, Petrovitch H, Launer LJ. 2002. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58:1629-1634 DOI 10.1212/WNL.58.11.1629.
38. Poels MM, Ikram MA, van der Lugt A, Hofman A, Niessen WJ, Krestin GP, Breteler MM, Vernooij MW. 2012. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam scan study. Neurology 31:78(5):326-333 DOI 10.1212/WNL.0b013e3182452928.
39. Pollard KS, Gilbert HN, Ge Y, Taylor S, Dudoit S. 2013. Multtest: resampling-based multiple hypothesis testing, R package version 2.16.0. www.bioconductor.org/packages/release/bioc/html/multtest.html.
40. Pulliainen V, Hokkanen L, Salo J, Ḧanninen T. 1999. CERAD kognitiivinen tehẗav̈asarja ja k̈asikirja [Finnish version of the CERAD neuropsychological battery. Manual]. Kuopio: Suomen Alzheimertutkimusseura ry.
41. R Core Team. 2013. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. Available at http://www.R-project.org/.
42. Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J. 2009. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. ACTA Neuropathologica 118:115-130 DOI 10.1007/s00401-009-0501-8.
43. Soffer D. 2006. Cerebral amyloid angiopathy-a disease or age-related condition. IMAJ 8:803-806.
44. Sotaniemi M, Pulliainen V, Hokkanen L, Pirttil̈a T, Hallikainen I, Soininen H, Ḧanninen T. 2012. CERAD-neuropsychological battery in screening mild Alzheimer's disease. ACTA Neurologica Scandinavica 125:16-23 DOI 10.1111/j.1600-0404.2010.01459.x.
45. Stroop JR. 1935. Studies of interference in serial verbal reactions. Journal of Experimental Psychology 18:643-662 DOI 10.1037/h0054651.
46. Thomas AJ, O'Brien JT, Davis S, Ballard C, Barber R, Kalaria RN, Perry RH. 2002. Ischemic basis for deep white matter hypertensities in major depression: a neuropathological study. Archives of General Psychiatry 59:785-792 DOI 10.1001/archpsyc.59.9.785.
47. Wechsler D. 1981. Wechsler adult intelligence scale-revised: manual. New York: The Psychological Corporation.
48. Wechsler D. 1987. Wechsler memory scale-revised: manual. New York: The Psychological Corporation.
49. Wechsler D. 1992. Wechslerin Aikuisten ̈alykkyysasteikko (WAIS-R) K̈asikirja. Helsinki: Psykologien Kustannus Oy.
50. Wechsler D. 1996. Wechslerin muistiasteikko (WMS-R) K̈asikirja. Helsinki: Psykologien KustannusOy.
51. Wechsler D. 1997. Wechsler memory scale, 3rd edition. San Antonio, TX: The Psychological Corporation.
52. Wechsler D. 2007. Wechslerin muistiasteikko (WMS-III) K̈asikirja. Helsinki: Psykologien Kustannus Oy.
53. Werring DJ, Frazer DW, Coward LJ, Losseff NA,Watt H, Cipolotti L, Brown MM, J̈ager HR. 2004. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 127:2265-2275 DOI 10.1093/brain/awh253.
54. Yamada M. 2000. Cerebral amyloid angiopathy: an overview. Neuropathology 1:8-22 DOI 10.1046/j.1440-1789.2000.00268.x